Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ANAB | ANAPTYSBIO INC | $1.79B | $62.34 | $78.89 | 26.55% | Strong Buy | 9 | 5.41% | N/A | -219.87% | -22.45% | |||
| ELTX | ELICIO THERAPEUTICS INC | $189.85M | $10.32 | $18.00 | 74.42% | Strong Buy | 3 | N/A | N/A | -2,351.23% | -148.74% | |||
| DSGX | DESCARTES SYSTEMS GROUP INC | $6.22B | $72.32 | $95.67 | 32.28% | Strong Buy | 6 | N/A | N/A | N/A | N/A | |||
| MGNX | MACROGENICS INC | $186.85M | $2.94 | $5.67 | 92.76% | Strong Buy | 3 | -3.17% | N/A | -50.14% | -10.85% | |||
| RAPP | RAPPORT THERAPEUTICS INC | $1.58B | $33.00 | $54.75 | 65.91% | Strong Buy | 4 | N/A | N/A | -45.84% | -43.36% | |||
| BLZE | BACKBLAZE INC | $241.19M | $4.18 | $7.50 | 79.43% | Strong Buy | 4 | 10.16% | N/A | -16.50% | -7.16% | |||
| XNCR | XENCOR INC | $852.20M | $11.62 | $26.00 | 123.75% | Strong Buy | 5 | 9.44% | N/A | -22.57% | -16.38% | |||
| PCOR | PROCORE TECHNOLOGIES INC | $8.40B | $55.98 | $74.23 | 32.60% | Strong Buy | 13 | 13.89% | N/A | N/A | N/A | |||
| ASST | STRIVE INC | $996.58M | $14.41 | $23.50 | 63.08% | Strong Buy | 4 | N/A | N/A | -2.18% | -1.70% | |||
| PHAR | PHARMING GROUP NV | $1.15B | $16.36 | $38.33 | 134.38% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| EXOD | EXODUS MOVEMENT INC | $210.77M | $7.07 | $22.00 | 211.17% | Strong Buy | 3 | 9.76% | N/A | N/A | N/A | |||
| AGBK | AGI INC | $1.36B | $7.39 | $17.20 | 132.75% | Strong Buy | 5 | N/A | N/A | N/A | N/A | |||
| TRVI | TREVI THERAPEUTICS INC | $1.77B | $13.82 | $20.56 | 48.74% | Strong Buy | 9 | N/A | N/A | -19.54% | -18.51% | |||
| CABA | CABALETTA BIO INC | $309.48M | $2.78 | $19.67 | 607.45% | Strong Buy | 3 | N/A | N/A | -103.36% | -70.16% | |||
| WALD | WALDENCAST PLC | $97.85M | $0.76 | $2.00 | 162.12% | Strong Buy | 3 | 9.89% | N/A | -16.52% | -10.23% | |||
| AGMB | AGOMAB THERAPEUTICS NV | $523.43M | $10.74 | $32.00 | 197.95% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| IRON | DISC MEDICINE INC | $2.52B | $65.97 | $100.00 | 51.58% | Strong Buy | 7 | N/A | N/A | -16.04% | -14.71% | |||
| ARWR | ARROWHEAD PHARMACEUTICALS INC | $9.88B | $70.53 | $92.13 | 30.62% | Strong Buy | 8 | -23.98% | N/A | -56.04% | -19.86% | |||
| DMRA | DAMORA THERAPEUTICS INC | $1.44B | $23.93 | $43.40 | 81.36% | Strong Buy | 5 | N/A | N/A | N/A | N/A | |||
| TLX | TELIX PHARMACEUTICALS LTD | $3.53B | $10.43 | $21.50 | 106.14% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| SRRK | SCHOLAR ROCK HOLDING CORP | $5.32B | $46.30 | $57.10 | 23.33% | Strong Buy | 10 | N/A | N/A | -5.89% | -3.57% | |||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $147.23M | $2.57 | $11.00 | 328.02% | Strong Buy | 3 | -100.00% | N/A | -27.60% | -21.66% | |||
| ERAS | ERASCA INC | $2.83B | $9.11 | $18.00 | 97.59% | Strong Buy | 9 | N/A | N/A | -74.68% | -61.30% | |||
| MGPI | MGP INGREDIENTS INC | $409.47M | $19.16 | $28.75 | 50.05% | Strong Buy | 4 | 0.12% | N/A | 9.43% | 5.32% | |||
| CPS | COOPER-STANDARD HOLDINGS INC | $511.47M | $29.00 | $51.88 | 78.91% | Strong Buy | 3 | 5.80% | N/A | -126.10% | 5.74% | |||
| BLSH | BULLISH | $5.51B | $36.51 | $50.50 | 38.32% | Strong Buy | 6 | -86.97% | N/A | 7.68% | 6.25% | |||
| DC | DAKOTA GOLD CORP | $707.64M | $5.30 | $9.63 | 81.75% | Strong Buy | 3 | N/A | N/A | -34.22% | -33.24% | |||
| BIOA | BIOAGE LABS INC | $748.24M | $16.86 | $51.50 | 205.46% | Strong Buy | 6 | -34.90% | N/A | -61.73% | -56.95% | |||
| ALXO | ALX ONCOLOGY HOLDINGS INC | $207.94M | $1.58 | $4.33 | 174.24% | Strong Buy | 3 | N/A | N/A | -356.51% | -156.87% | |||
| ARVN | ARVINAS INC | $628.10M | $9.82 | $16.88 | 71.84% | Strong Buy | 8 | -19.88% | N/A | -22.40% | -13.54% | |||
| PEPG | PEPGEN INC | $107.13M | $1.55 | $11.75 | 658.06% | Strong Buy | 4 | N/A | N/A | -39.37% | -33.38% | |||
| DEFT | DEFI TECHNOLOGIES INC | $290.91M | $0.75 | $2.17 | 187.40% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | $2.10B | $22.48 | $48.40 | 115.30% | Strong Buy | 5 | N/A | N/A | N/A | N/A | |||
| RLMD | RELMADA THERAPEUTICS INC | $773.04M | $7.37 | $12.40 | 68.25% | Strong Buy | 5 | N/A | N/A | -92.75% | -85.36% | |||
| PERI | PERION NETWORK LTD | $400.79M | $10.27 | $14.50 | 41.19% | Strong Buy | 3 | 9.07% | N/A | N/A | N/A | |||
| IPX | IPERIONX LTD | $977.02M | $29.05 | $55.33 | 90.48% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| KWR | QUAKER CHEMICAL CORP | $2.31B | $133.25 | $167.00 | 25.33% | Strong Buy | 3 | 4.26% | N/A | 13.86% | 6.80% | |||
| CNTX | CONTEXT THERAPEUTICS INC | $215.00M | $2.34 | $6.60 | 182.05% | Strong Buy | 5 | N/A | N/A | -45.97% | -40.59% | |||
| ABVX | ABIVAX SA | $8.34B | $106.24 | $145.00 | 36.48% | Strong Buy | 8 | N/A | N/A | N/A | N/A | |||
| BILL | BILL HOLDINGS INC | $3.69B | $37.25 | $61.00 | 63.76% | Strong Buy | 11 | 11.64% | N/A | 13.55% | 5.09% | |||
| TYRA | TYRA BIOSCIENCES INC | $1.82B | $33.79 | $51.25 | 51.69% | Strong Buy | 8 | N/A | N/A | -50.97% | -46.74% | |||
| ELAN | ELANCO ANIMAL HEALTH INC | $10.84B | $21.80 | $28.50 | 30.73% | Strong Buy | 8 | 6.12% | N/A | 11.37% | 5.57% | |||
| WPM | WHEATON PRECIOUS METALS CORP | $56.70B | $124.89 | $159.60 | 27.79% | Strong Buy | 5 | N/A | N/A | N/A | N/A | |||
| DCGO | DOCGO INC | $69.82M | $0.71 | $2.38 | 235.93% | Strong Buy | 4 | -5.38% | N/A | -5.88% | -3.90% | |||
| MARA | MARA HOLDINGS INC | $4.08B | $10.72 | $18.00 | 67.91% | Strong Buy | 7 | 1.24% | N/A | N/A | N/A | |||
| CLFD | CLEARFIELD INC | $381.96M | $27.91 | $43.50 | 55.86% | Strong Buy | 4 | 12.49% | N/A | 6.97% | 6.49% | |||
| NKTX | NKARTA INC | $191.77M | $2.69 | $11.33 | 321.30% | Strong Buy | 3 | N/A | N/A | -34.69% | -26.80% | |||
| LTM | LATAM AIRLINES GROUP SA | $26.94B | $46.91 | $61.67 | 31.46% | Strong Buy | 3 | N/A | N/A | N/A | N/A | |||
| NEXN | NEXXEN INTERNATIONAL LTD | $207.69M | $7.38 | $11.07 | 50.01% | Strong Buy | 7 | N/A | N/A | N/A | N/A | |||
| MMED | MINIMED GROUP INC | $3.38B | $12.02 | $22.56 | 87.65% | Strong Buy | 9 | N/A | N/A | 6.48% | 5.16% | |||
| LBRX | LB PHARMACEUTICALS INC | $877.16M | $30.59 | $40.33 | 31.85% | Strong Buy | 3 | N/A | N/A | -48.34% | -46.55% | |||
| KRRO | KORRO BIO INC | $181.87M | $12.61 | $19.75 | 56.62% | Strong Buy | 8 | N/A | N/A | -360.63% | -163.43% | |||
| SLDB | SOLID BIOSCIENCES INC | $693.66M | $7.05 | $16.50 | 134.04% | Strong Buy | 8 | N/A | N/A | 8.55% | 6.62% | |||
| PCVX | VAXCYTE INC | $8.25B | $57.32 | $105.00 | 83.18% | Strong Buy | 3 | N/A | N/A | -9.50% | -8.49% | |||
| CGEM | CULLINAN THERAPEUTICS INC | $777.76M | $12.85 | $33.40 | 159.92% | Strong Buy | 5 | N/A | N/A | -43.20% | -39.38% | |||
| CGTX | COGNITION THERAPEUTICS INC | $105.44M | $1.18 | $3.33 | 182.46% | Strong Buy | 3 | N/A | N/A | -66.49% | -47.09% | |||
| CRVO | CERVOMED INC | $33.79M | $3.65 | $22.00 | 502.74% | Strong Buy | 4 | N/A | N/A | -19.17% | -15.27% | |||
| CATX | PERSPECTIVE THERAPEUTICS INC | $447.76M | $3.93 | $12.63 | 221.25% | Strong Buy | 8 | 1.69% | N/A | -57.07% | -44.26% | |||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $449.76M | $8.81 | $30.67 | 248.09% | Strong Buy | 6 | -21.45% | N/A | -36.97% | -32.99% | |||
| KYMR | KYMERA THERAPEUTICS INC | $6.65B | $81.51 | $119.57 | 46.69% | Strong Buy | 21 | 3.01% | N/A | -21.72% | -19.69% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.